Secondary Logo

Journal Logo

Concentration of levobupivacaine solutions is labelled differently than that of other local anaesthetic solutions

Rosenberg, P. H.*

European Journal of Anaesthesiology: February 2007 - Volume 24 - Issue 2 - p 207
doi: 10.1017/S0265021506001712

*Department of Anaesthesiology and Intensive Care Medicine, Helsinki University Hospital, Helsinki, Finland

Correspondence to: Per H. Rosenberg, Department of Anaesthesiology and Intensive Care Medicine, Helsinki University Hospital, PB 340, Helsinki, 00029 HUS, Finland. E-mail:; Tel: +358 9 47172510; Fax: +358 9 47174017

Accepted for publication 9 July 2006

First published online 11 October 2006


It seems to be difficult for both clinicians and investigators to realize that there is a difference between the base and the salt of the drug molecule when local anaesthetic concentrations are reported. Di Donato and colleagues [1] have made an error when reporting the concentration of levobupivacaine in their paper published recently in EJA.

In contrast to the labelling principle of all other clinically used local anaesthetics the concentration of levobupivacaine (Chirocaine®) on the marketed ampoule is given as the concentration of the base-form of the molecule. Therefore, a 0.5% levobupivacaine concentration is, in fact, 0.56% when the concentration of the solution would be given according to the hydrochloride-form (salt) of the molecule, i.e., the form in which it exists in the injectable solution.

This error has been pointed out repeatedly in the anaesthesiology literature, the most recent note was published in 2005 [2].

Perhaps such a small error in actual levobupivacaine concentration does not make any difference in clinical practice, but this 12.6% difference may influence scientific evaluation and the interpretation of equipotency in comparison with other local anaesthetics. It can be assumed that the small difference in favour of levobupivacaine in the study by Di Donato and colleagues [1] would have been eliminated had the correct concentration (0.5% instead of 0.56%) and dose (45 mg instead of 50.4 mg) of levobupivacaine-HCl been chosen.

Back to Top | Article Outline


1. Di Donato A, Fontana C, Lancia F, Celleno D. Efficacy and comparison of 0.5% levobupivacaine with 0.75% ropivacaine for peribulbar anaesthesia in cataract surgery. Eur J Anaesthesiol 2006; 23: 487–490.
2. Rosenberg PH, Schug SA. Levobupivacaine base and levobupivacaine hydrochloride. Br J Anaesth 2005; 94: 544.
© 2007 European Society of Anaesthesiology